Literature DB >> 27109393

Coagulation Profile at Diagnosis in Patients with Acute Lymphoblastic Leukemia.

Shivali Sehgal1, Sunita Sharma2, Jagdish Chandra3, Anita Nangia2.   

Abstract

OBJECTIVE: To evaluate the coagulation parameters at the time of diagnosis in pediatric acute lymphoblastic leukemia (ALL) patients.
METHODS: A total of 65 newly diagnosed ALL patients upto 18 y of age along with 30 age and sex matched controls were included in the study. Coagulation tests including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen (FBG) assay, D-dimer (D-DI) assay, Coagulation inhibitor levels and tests for fibrinolysis were performed.
RESULTS: At baseline, APTT of the patients was significantly prolonged (p 0.033), but PT and fibrinogen were comparable in the two groups. Protein C (PC) and Protein S (PS) were both significantly reduced in the cases, while antithrombin was comparable to control values (p < 0.001, p < 0.001 &amp; p = 0.828 respectively). Tissue plasminogen activator levels (tPA) were significantly lower in the cases (p < 0.001) but Plasminogen activator inhibitor type 1 (PAI-1) values were comparable. D-DI levels were significantly high (p < 0.001).
CONCLUSIONS: The onset of leukemia is associated with hemostatic derangement favouring hypercoagulability. The coagulopathy is due to thrombin activation (as evidenced by raised d-dimer). The decreased fibrinolysis (due to reduced tPA and raised PAI-1) and low levels of PC and PS contribute to the hypercoagulable state at the time of diagnosis.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Coagulation profile; Pediatric

Mesh:

Substances:

Year:  2016        PMID: 27109393     DOI: 10.1007/s12098-016-2114-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

1.  Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.

Authors:  V Mall; K B Thomas; S Sauter; C M Niemeyer; A H Sutor
Journal:  Klin Padiatr       Date:  1999 Jul-Aug       Impact factor: 1.349

2.  Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.

Authors:  A F Oner; A Gürgey; S Kirazli; H Okur; B Tunç
Journal:  Leuk Lymphoma       Date:  1999-04

3.  Incidence of malignant tumors in U. S. children.

Authors:  J L Young; R W Miller
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

4.  Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.

Authors:  Paola Giordano; Angelo Claudio Molinari; Giovanni Carlo Del Vecchio; Paola Saracco; Giovanna Russo; Maria Altomare; Paolo Perutelli; Nicoletta Crescenzio; Nicola Santoro; Marina Marchetti; Domenico De Mattia; Anna Falanga
Journal:  Am J Hematol       Date:  2010-05       Impact factor: 10.047

5.  The clinical and biological correlates of coagulopathy in children with acute leukemia.

Authors:  R C Ribeiro; C H Pui
Journal:  J Clin Oncol       Date:  1986-08       Impact factor: 44.544

6.  Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.

Authors:  L G Mitchell; J M Halton; P A Vegh; R D Barr; T Venneri; K M Pai; M E Andrew
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-05

7.  Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.

Authors:  Grace H Ku; Richard H White; Helen K Chew; Danielle J Harvey; Hong Zhou; Ted Wun
Journal:  Blood       Date:  2008-12-16       Impact factor: 22.113

8.  Maturation of the hemostatic system during childhood.

Authors:  M Andrew; P Vegh; M Johnston; J Bowker; F Ofosu; L Mitchell
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

9.  Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency.

Authors:  L Mitchell; H Hoogendoorn; A R Giles; P Vegh; M Andrew
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

10.  Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia.

Authors:  A C Homans; M E Rybak; R L Baglini; C Tiarks; M E Steiner; E N Forman
Journal:  J Clin Oncol       Date:  1987-05       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.